Want to join the conversation?
Pivotal Research Group analyst Tim Ramey questions capital allocation from a risk management perspective. $FLO says that it has done a good job balancing overall allocation. From a risk perspective, $FLO has been fairly a risk adverse company and it will be mindful of its cash position as it makes decisions pm how to allocate capital going forward.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?